Clinical/scientific notes

Shirin S. Issa; Steven Herskovitz; Richard B. Lipton

doi:10.1212/WNL.0b013e318203e91a

Clinical/scientific notes

Shirin S. Issa, Steven Herskovitz, Richard B. Lipton

Neurology

Research output: Contribution to journal › Comment/debate › peer-review

9 Scopus citations

Original language	English (US)
Pages (from-to)	100-101
Number of pages	2
Journal	Neurology
Volume	76
Issue number	1
DOIs	https://doi.org/10.1212/WNL.0b013e318203e91a
State	Published - Jan 4 2011

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0b013e318203e91a

Cite this

@article{3cd97ad51a604044a05ed02f701964f8,

title = "Clinical/scientific notes",

author = "Issa, {Shirin S.} and Steven Herskovitz and Lipton, {Richard B.}",

note = "Funding Information: Disclosure: Dr. Issa reports no disclosures. Dr. Herskovitz receives royalties from the publication of Peripheral Neuropathies in Clinical Practice (Oxford University Press, 2010) and served as an expert witness on behalf of the U.S. Department of Health and Human Services, Vaccine Injury Compensation Program. Dr. Lipton serves/has served on scientific advisory boards for and received funding for travel from Bayer Schering Pharma, Merck Serono, GlaxoSmithKline, Endo Pharmaceuticals, Kowa Pharmaceuticals America, Inc., Allergan, Inc., Neuralieve Inc., and Ortho-McNeil-Janssen Pharmaceuticals, Inc.; has received funding for travel from the American Headache Society and the Diamond Headache Center; serves as Associate Editor of Cephalalgia and on the editorial boards of Neurology{\textregistered} and Headache; receives royalties from publishing Headache in Clinical Practice (Isis Medical Media, 2002), Headache in Primary Care (Isis Medical Media, 1999), Wolff's Headache (Oxford University Press, 2001, 2008), Managing Migraine: A Physician's Guide (BC Decker, 2008), and Managing Migraine: A Patient's Guide (BC Decker, 2008); has received speaker honoraria from the National Headache Foundation, the University of Oklahoma, the American Academy of Neurology, the Annenberg Foundation, Merck Serono, GlaxoSmithKline, and Coherex Medical; receives research support from the American Headache Society, National Headache Foundation, the Migraine Research Foundation, and the NIH (PO1AG03949 [Program Director, Project Leader], PO1AG027734 [Project Leader], RO1AG25119 [Co-I], K23AG030857 [Co-Mentor], K23NS05140901A1 [Co-Mentor], and K23NS47256 [Mentor]); and holds stock options in Minster Pharmaceuticals plc. ",

year = "2011",

month = jan,

day = "4",

doi = "10.1212/WNL.0b013e318203e91a",

language = "English (US)",

volume = "76",

pages = "100--101",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Clinical/scientific notes

AU - Issa, Shirin S.

AU - Herskovitz, Steven

AU - Lipton, Richard B.

N1 - Funding Information: Disclosure: Dr. Issa reports no disclosures. Dr. Herskovitz receives royalties from the publication of Peripheral Neuropathies in Clinical Practice (Oxford University Press, 2010) and served as an expert witness on behalf of the U.S. Department of Health and Human Services, Vaccine Injury Compensation Program. Dr. Lipton serves/has served on scientific advisory boards for and received funding for travel from Bayer Schering Pharma, Merck Serono, GlaxoSmithKline, Endo Pharmaceuticals, Kowa Pharmaceuticals America, Inc., Allergan, Inc., Neuralieve Inc., and Ortho-McNeil-Janssen Pharmaceuticals, Inc.; has received funding for travel from the American Headache Society and the Diamond Headache Center; serves as Associate Editor of Cephalalgia and on the editorial boards of Neurology® and Headache; receives royalties from publishing Headache in Clinical Practice (Isis Medical Media, 2002), Headache in Primary Care (Isis Medical Media, 1999), Wolff's Headache (Oxford University Press, 2001, 2008), Managing Migraine: A Physician's Guide (BC Decker, 2008), and Managing Migraine: A Patient's Guide (BC Decker, 2008); has received speaker honoraria from the National Headache Foundation, the University of Oklahoma, the American Academy of Neurology, the Annenberg Foundation, Merck Serono, GlaxoSmithKline, and Coherex Medical; receives research support from the American Headache Society, National Headache Foundation, the Migraine Research Foundation, and the NIH (PO1AG03949 [Program Director, Project Leader], PO1AG027734 [Project Leader], RO1AG25119 [Co-I], K23AG030857 [Co-Mentor], K23NS05140901A1 [Co-Mentor], and K23NS47256 [Mentor]); and holds stock options in Minster Pharmaceuticals plc.

PY - 2011/1/4

Y1 - 2011/1/4

UR - http://www.scopus.com/inward/record.url?scp=78751631066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751631066&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e318203e91a

DO - 10.1212/WNL.0b013e318203e91a

M3 - Comment/debate

C2 - 21205699

AN - SCOPUS:78751631066

SN - 0028-3878

VL - 76

SP - 100

EP - 101

JO - Neurology

JF - Neurology

IS - 1

ER -

Clinical/scientific notes

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this